## Race Against Blood Cancer Annual Report for Year Ended 31 March 2025 The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the fiscal year 1st April 2024 to 31st March 2025. _In the UK blood cancer patients from a Global Majority background have a significantly higher post-diagnosis mortality rate when compared to White Northern European patients. A White Northern European patient has a 70% or more chance of finding a match compared to a 20% or less chance for a Global Majority patient._ Race against Blood Cancer was founded in 2015 by a group of friends who received the devastating news of a close friend s blood cancer diagnosis. A lifesaving match depends on finding a stem cell or bone marrow donor with a similar ethnicity as the patient and it was even more devastating to realise that the chance of finding a match was significantly lower because of a mixed ethnic background. This group of friends were inspired to join the fight for health equality and give every blood cancer patient the best possible chance of surviving blood cancer regardless of background. At RABC our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match. Our mission is to save more lives by addressing the stark inequality of finding a stem cell match for Global Majority blood cancer patients by recruiting more people from these backgrounds onto the UK s register of stem cell and bone marrow donors. To achieve our mission we deliver one of the only UK programmes aiming to engage the public in a face-to-face capacity and recruit new people from Global Majority backgrounds onto the donor register. We focus our efforts on partnering with organisations and in areas which have high levels of our target population, building trust and relationships with organisations and communities to recruit as many Global Majority donors as possible each year. Our 'Save a Life Programme (SLP) has developed over 9-years and consists of Donor Drive events, where we directly sign people up to the stem cell and bone marrow donor register. We ve recently added separate Education Talks, which raise awareness of the issue, where each talk is followed by a Donor Drive event. This approach slows our recruitment in real terms but invests in longer-term attitude change in people we hope will become lifelong advocates. Our programme is delivered across the Midlands with intermittent activity in London, and we have a national reach because the donor registry is accessed across the UK. For countless people living with blood cancer and other blood disorders, the search for a matching stem cell donor is a race against time. Your willingness to donate could offer them the priceless gift of a second chance at life. Page 1 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ ## Chair of Trustees Statement for period April 2024 to March 2025 ## Introduction As we approach our 10-year anniversary, its critical that we align on the strategic delivery plan and expectations to safeguard the future of the charity. Since inception, we have signed up over 11,000 donors and more than 20 potential lifesaving donor matches, making us one of the biggest UK partners to DKMS and, more recently, Anthony Nolan. Despite our achievements, we ve found it challenging to achieve financial stability and face to face recruitment events post-COVID, though a new strategic plan is currently being prepared to address both these issues going forward. Our recruitment of a specialist fundraising trustee in the previous period has paid dividends and we are moving in a positive direction year-on-year with our fundraising. ## Achievements and Challenges During the period from April 2024 to March 2025, we hosted 69 events (donor drives and YEP presentations), signing up over 787 potential lifesavers. We kicked off a multi-year partnership with The Anthony Nolan charity aimed at funding our Youth Education Programme (YEP). We contributed creation of the first Global Majority recruitment targets and we also began rebuilding our website, funded by The National Lottery. However, we faced challenges such as difficulty in generating funds, struggles in recruiting volunteers and a decrease in the average number of sign-ups per donor drive as we shifted to more closed environments like schools and colleges as part of the YEP. These challenges only strengthen our resolve to set and achieve more ambitious Global Majority recruitment targets, delivering high quality donors who go on to donate when matched. ## Impact Stories The APPG report launch allowed us to build closer relationships with key stakeholders across the Department for Health, NHS Blood & Transplant, and other smaller charities. Our collaboration with Anthony Nolan significantly improved donor recruitment from two of our target groups from males and those aged under 30 both of whom offer better outcomes for blood cancer patients with less risk of complications. ## Partner Feedback Holly Gooch, Partnerships Manager at Anthony Nolan, shared her positive feedback: been working in Partnership since 2019 and really stepped up in activity from 2021 when RABC ran a series of very successful donor recruitment events with the National Citizen Service. At the end of 2023, we updated our recruitment agreement and RABC proposed an ambitious recruitment strategy and KPIs, which I am delighted to say they have surpassed. Page 2 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ Race Against Blood Cancer set out to recruit 300 people to the register across the first 3 months of this year, a target which is approximately 3 times the number of people they recruited in the entirety of last year. In this partnership, we want to recruit quality donors who we know will provide the best possible outcomes for patients. Part of this is recruiting young donors, between the ages of 16-23. 84% of R -23 (compared to Anthony Nolan overall which is 80%). The other key area of focus is recruiting more donors from minority ethnic backgrounds as we are committed, at RABC and AN, to ensuring that every patient has access to a stem cell transplant. 38% of the people RABC recruited are from minority ethnic backgrounds, compared to 23% on average across Anthony Nolan. Not only are RABC committed to recruiting donors, but they have also cruiting quality donors who will go on to save the lives of patients now and in the future. It has been so impressive to see RABC pivot their approach to recruitment this year to engage more young people - forging new connections, trialling new approaches and successfully shifting their focus to a younger, more targeted audience. For the year ahead, RABC are looking to develop an education programme to deliver to local schools and colleges so they can reach even more young people where ts, bust myths and help each individual to make a safe, informed decision about donation. see the lifesaving impact they have in the local community and beyo ## Financial Overview Delivering our essential programme of work is dependent on our fundraising efforts which are led by our fundraising trustee, supported by the General Manager. For the year ended 31/03/2025, there was a surplus of 32,228 compared to income deficit of 16,515 in prior year (ending 31/03/2024). In 2024/25 our income was 92,733 (2023/24: 43,242) versus our expenditure of 60,505 (2023/24: 59,757). This represented an improvement as we began to feel the benefit of bringing on our fundraising specialist trustee. However, to move towards our ambitions, we require a more diverse mix of income streams and better distribution across these streams. Income comes primarily from Trusts and Grants (90%) with individual donations and individual supporters fundraising effort making up the remainder (10%). We are in the final stretch of website redevelopment and looking forward to a new site that enables our ambitions to build stronger ongoing relationships with our supporters, host patient appeals, and actively engage with our audience. ## Strategic Goals and Objectives Our ambitions for the next three fiscal years (FY 25-26, 26-27, and 27-28) include expanding our geographical coverage, establishing financial sustainability, further professionalising our structure and operations, educating people with a focus on youth-centred programmes, and collaborating through partnerships. Page 3 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ ## Key Actions for 2025-2026 Deepen and consolidate Youth Education Programme activity. Increase donor recruitment figures in the over 30s through a new corporate activity programme Introduction of a new three-year organisational strategy for 2025-2028 Skills audit and recruitment of new trustees. A renewed focus on development of fundraising income streams. Re-establish activities in London. ## Governance and Leadership Race Against Blood Cancer is a Charitable Incorporated Organisation (CIO), registered with the Charity Commission for England and Wales under number 1162696. The charity was formally established by constitution on 16 July 2015. Our team consists of a General Manager (0.5 FTE), 1 FTE Community Engagement Manager (CEM), 7 trustees, and a pool of 20 volunteers supporting our CEM. ## Stakeholder Feedback We received positive feedback from donors who appreciated our transparency and impact stories. Volunteers expressed a sense of fulfilment and pride in being part of our mission. Beneficiaries, particularly patients and their families, were grateful for the hope and support provided by our efforts. ## Acknowledgements The Trustees would like to thank the following individuals, companies and charitable trusts and organisations for their support throughout 2024/25: 10,000 Donors Coventry College Sandwell College African Caribbean Leukaemia Trust (ACLT) Coventry University Shrewsbury College Group South & City College Anthony Nolan Defined Ridez Birmingham DKMS UK Dudley College of Technology Telford United FC National Black, Asian, Mixed and Minority Ethnic Transplant Heart of Worcestershire Association (NBTA) College The Hex Group Newcastle and Stafford Sue Harris Trust Colleges Group Wakes Team Margot Park Run Walton Wobble 5k Anytime Fitness Really Neet The National Lottery Signed on behalf of the board on 23 October 2025 Jacob Knox-Hooke Chair of Trustees Page 4 Race Against Blood Cancer is a registered charity, number 1162696 Registered office address: 71-75 Shelton Street, London, WC2H 9JQ ## **Race Against Blood Cancer** **Charity No. 1162696** **Company No. CE005053** **Trustees' Report and Unaudited Accounts** **31 March 2025** **Race Against Blood Cancer Contents** ||Pages| |---|---| |Trustees' Annual Report|6| |Independent Examiner's Report|7| |Statement of Financial Activities|8| |Summary Income and Expenditure Account|9| |Balance Sheet|10| |Statement of Cash flows|11| |Notes to the Accounts|12 to 17| |Detailed Statement of Financial Activities|18 to 19| Page 5 **Race Against Blood Cancer** ## **Trustees Annual Report** The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2025. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Company No. CE005053** ## **Charity No. 1162696** ## **Registered Office** 71-75 Shelton Street Covent Garden London WC2H 9JQ ## **Directors and Trustees** The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year: J. Bates G. Fiske (Resigned 1 October 2024) D. Gardner M.M. Gardner J.I.B. Knox-Hooke H. Shah R.O. Sisupalan (Appointed on 08 October 2024) B. Westwood ## **Accountants** Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities. The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102). Signed on behalf of the board J.I.B. Knox-Hooke Trustee 23 October 2025 Page 6 **Race Against Blood Cancer** ## **Independent Examiners Report** ## **Independent Examiner's Report to the trustees of Race Against Blood Cancer** I report to the charity trustees on my examination of the financial statements of Race Against Blood Cancer for the year ended 31 March 2025. ## **Responsibilities and basis of report** As the charity's trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act. Having satisfied myself that the financial statements of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's financial statements as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. ## **Independent examiner's statement** I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe: - Act other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination; or - the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. Vicky Newham CPAA Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL 23 October 2025 Page 7 **Race Against Blood Cancer** ## **Statement of Financial Activities** ## **for the year ended 31 March 2025** |**Notes**
**Income and endowments**
**from:**
Donations and legacies
4
Other
5
**Total**
**Expenditure on:**
Raising funds
6
Other
7
**Total**
Net gains on investments
**Net income/(expenditure)**
8
Transfers between funds
**Net income/(expenditure)**
**before other gains/(losses)**
**Other gains and losses**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|**Unrestricted**
**funds**
**2025**
82,810
127|**Restricted**
**funds**
**2025**
1,000
8,796|**Total funds**
**2025**
83,810
8,923|**Total funds**
**2024**
34,385
8,857| |---|---|---|---|---| ||82,937
1,608
50,424|9,796
-
8,473|92,733
1,608
58,897|43,242
694
59,063| ||52,032
-|8,473
-|60,505
-|59,757
-| ||30,905
-|1,323
-|32,228
-|(16,515)
-| ||30,905|1,323|32,228|(16,515)| ||30,905
(1,770)|1,323
6,997|32,228
5,227|(16,515)
21,742| ||29,135|8,320|37,455|5,227| Page 8 **Race Against Blood Cancer** ## **Summary Income and Expenditure Account** ## **for the year ended 31 March 2025** |Income
**Gross income for the year**
Expenditure
Interest payable
**Total expenditure for the year**
Net income/(expenditure) before tax
for the year
**Net income /(expenditure )for the year**|**2025**
92,733
92,733
60,505
-
60,505
32,228
32,228|**2024**
43,242| |---|---|---| |||43,242| |||59,536
221| |||59,757| |||(16,515)| |||(16,515)| Page 9 **Race Against Blood Cancer** **Balance Sheet** ## **at 31 March 2025** |**Company No.**
**CE005053**
**Notes**
**2025**
**Current assets**
Cash at bank and in hand
42,826
42,826
**Creditors:**Amount falling due within one year
10
(4,662)
**Net current assets**
38,164
**Total assets less current liabilities**
38,164
**Creditors:**Amounts falling due after more than one year
11
(709)
**Net assets excluding pension asset or liability**
37,455
**Total net assets**
37,455
**The funds of the charity**
**Restricted funds**
12
Restricted income funds
8,320
8,320
**Unrestricted funds**
12
General funds
29,135
29,135
**Reserves**
12
**Total funds**
37,455|**2024**
13,758| |---|---| ||13,758
(4,502)| ||9,256
9,256
(4,029)| ||5,227| ||5,227| ||6,997| ||6,997
(1,770)| ||(1,770)| ||5,227| These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. For the year ended 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. Approved by the board on 23 October 2025 And signed on its behalf by: J.I.B. Knox-Hooke Trustee 23 October 2025 Page 10 **Race Against Blood Cancer** **Statement of Cash flows** ## **for the year ended 31 March 2025** |**Cash flows from operating activities**
**Net income/(expenditure) per Statement of Financial Activities**
**Adjustments for:**
Dividends, interest and rents from investments
Increase in trade and other payables
**Net cash provided by/(used in) operating activities**
**Cash flows from investing activities**
Dividends, interest and rents from investments
**Net cash from investing activities**
**Cash flows from financing activities**
Repayment of borrowings
**Net cash used in financing activities**
**Net increase/(decrease) in cash and cash equivalents**
**Cash and cash equivalents at the beginning of the year**
**Cash and cash equivalents at the end of the year**
**Components of cash and cash equivalents**
Cash and bank balances|**2025**
32,228
(8,923)
160
23,465
8,923
8,923
(3,320)
(3,320)
29,068
13,758
42,826
42,826
42,826|**2024**
(16,515)
(8,857)
522| |---|---|---| |||(24,850)
8,857| |||8,857| |||(2,974)| |||(2,974)| |||| |||(18,967)| |||32,725| |||13,758| |||| |||13,758| |||| |||13,758| Page 11 **Race Against Blood Cancer** **Notes to the Accounts** ## **for the year ended 31 March 2025** - 1 **Accounting policies** ## **Basis of preparation** The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. ## **Change in basis of accounting or to previous accounts** There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years. ## **Fund accounting** Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity. Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Revaluation funds These are unrestricted funds which include a revaluation reserve representing the restatement of investment assets at their market values. Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal. ## **Income** Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability. Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income. Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Page 12 **Race Against Blood Cancer Notes to the Accounts** ## **Expenditure** - Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates. - Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs. - Grants payable All grant expenditure is accounted for on an actual paid basis plus an accrual for grants that have been approved by the trustees at the end of the year but not yet paid. - Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs. - Other expenditure These are support costs not allocated to a particular activity. ## **Taxation** The charity is exempt from corporation tax on its charitable activities. ## **Cash and cash equivalents** Cash and cash equivalents comprise cash at bank and on hand. ## **Trade and other creditors** Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due. ## **Pension costs** The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds. ## 2 **Company status** The company is a private company limited by guarantee and consequently does not have share capital. Page 13 ## **Race Against Blood Cancer** ## **Notes to the Accounts** ## 3 **Statement of Financial Activities - prior year** |3
**Statement of Financial Activities - prior year**||||| |---|---|---|---|---| |**Income and endowments from:**
Donations and legacies
Other
**Total**
**Expenditure on:**
Raising funds
Other
**Total**
**Net income**
**Net income before other**
**gains/(losses)**
**Other gains and losses:**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
4
**Income from donations and legacies**
Donations From Events
General Donations
Regular Donations
5
**Other income**
Other Grant Income|**Unrestricted**
11,441
70,109
1,260
82,810
**Unrestricted**
127
127|**Unrestricted**
**funds**
**2024**
14,385
300
14,685
694
24,203
24,897
(10,212)
(10,212)
(10,212)
8,442
(1,770)
**Restricted**
-
1,000
-
1,000
**Restricted**
8,796
8,796|**Restricted**
**funds**
**2024**
20,000
8,557
28,557
-
34,860
34,860
(6,303)
(6,303)
(6,303)
13,300
6,997
**Total**
**2025**
11,441
71,109
1,260
83,810
**Total**
**2025**
8,923
8,923|**Total funds**
**2024**
34,385
8,857| |||||43,242
694
59,063| |||||59,757| |||||(16,515)| |||||(16,515)| |||||(16,515)
21,742| |||||5,227| |||||**Total**
**2024**
10,494
23,831
60| |||||34,385| |||||**Total**
**2024**
8,857| |||||8,857| Page 14 **Race Against Blood Cancer** ## **Notes to the Accounts** |6
**Expenditure on raising funds**
_Costs of generating voluntary_
_income_
Adhoc Donations MyDonate
Donations From Events
7
**Other expenditure**
Bank loan and overdraft
interest payable
Employee costs
Premises costs
General administrative costs
Legal and professional costs
8
**Net income/(expenditure) before transfers**
This is stated after charging:
Independent Examiner's fee
9
**Staff costs**
Salaries and wages
Pension costs
No employee received emoluments in excess
10 **Creditors:**
amounts falling due within one year
Bank loans and overdrafts
Other taxes and social security
Other creditors
Accruals|**Unrestricted**
-
46,804
450
1,500
1,670
50,424
of|**Unrestricted**
397
1,211
1,608
**Restricted**
-
5,353
-
3,120
-
8,473
**2025**
650
**2025**
51,059
1,098
52,157
**2025**
3,195
387
430
650
4,662|**Total**
**2025**
397
1,211
1,608
**Total**
**2025**
-
52,157
450
4,620
1,670
58,897|**Total**
**2024**
62
632| |---|---|---|---|---| |||||694| |||||**Total**
**2024**
221
50,544
-
3,014
5,284| |||||59,063| |||||**2024**
650
**2024**
49,530
1,014| |||||50,544| |||||**2024**
3,195
445
212
650| |||||4,502| Page 15 **Race Against Blood Cancer** ## **Notes to the Accounts** ## 11 **Creditors:** amounts falling due after more than one year **----- Start of picture text -----**
2025 2024
Bank loans and overdrafts 709 4,029
709 4,029
12 Movement in funds
Incoming
resources
At 31
(including Resources
March
other expended
2025
At 1 April gains/losses
2024 )
Restricted funds:
Restricted income funds:
- -
Shropshire Community Fund 1,000 1,000
The National Lottery 6,997 8,796 (8,473) 7,320
Total 6,997 9,796 (8,473) 8,320
Unrestricted funds:
General funds (1,770) 82,937 (52,032) 29,135
Total funds 5,227 92,733 (60,505) 37,455
Purposes and restrictions in relation to the funds:
Restricted funds:
Shropshire Community Fund Youth Engagement Programme
The National Lottery GM Salary and Website development
**----- End of picture text -----**
13 **Analysis of net assets between funds** |**Analysis of net assets between funds**||| |---|---|---| |Net current assets
Creditors due in more than one year and
provisions|**Unrestricted**
**funds**
38,164
(709)
37,455|**Total**
38,164
(709)| |||37,455| Page 16 **Race Against Blood Cancer** ## **Notes to the Accounts** ## 14 **Reconciliation of net debt** |14 **Reconciliation of net debt**|||| |---|---|---|---| |Cash and cash equivalents
Bank loans
Net debt|**At 1 April**
**2024**|**Cash flows**|**At 31**
**March**
**2025**| ||13,758|29,068|42,826| ||13,758
(7,224)
(7,224)
6,534|29,068
3,320
3,320
32,388|42,826
(3,904)| ||||(3,904)| ||||38,922| ||||| |15 **Commitments**
**_Pension commitments_**
The pension cost charge to the company
amounted to:
16 **Related party disclosures**
**_Controlling party_**|**2025**
1,098||**2024**
1,014| ||||| The company is limited by guarantee and has no share capital; thus no single party controls the company. Page 17 **Race Against Blood Cancer** ## **Detailed Statement of Financial Activities** ## **for the year ended 31 March 2025** |**Income and endowments from:**
Donations and legacies
Donations From Events
General Donations
Regular Donations
Other
Other Grant Income
**Total income and endowments**
**Expenditure on:**
Costs of generating donations and
legacies
Adhoc Donations MyDonate
Donations From Events
**Total of expenditure on raising**
**funds**
Other expenditure
Bank loan and overdraft interest
payable
Employee costs
Salaries/wages
Pension costs
Premises costs
Rent
General administrative costs,
including depreciation and
amortisation
General insurances
Software, IT support and related
costs
Stationery and printing
Telephone, fax and broadband
Legal and professional costs|**Unrestricted**
**funds**
**2025**
11,441
70,109
1,260|**Restricted**
**funds**
**2025**
-
1,000
-|**Total funds**
**2025**
11,441
71,109
1,260|**Total funds**
**2024**
10,494
23,831
60| |---|---|---|---|---| ||82,810|1,000|83,810|34,385| ||127|8,796|8,923|8,857| ||127|8,796|8,923|8,857| ||82,937
397
1,211|9,796
-
-|92,733
397
1,211|43,242
62
632| ||1,608|-|1,608|694| ||1,608
-|-
-|1,608
-|694
221| ||-|-|-|221| ||45,706
1,098|5,353
-|51,059
1,098|49,530
1,014| ||46,804|5,353|52,157|50,544| ||450|-|450|-| ||450|-|450|-| ||219
457
141
683|-
3,120
-
-|219
3,577
141
683|233
1,980
162
639| ||1,500|3,120|4,620|3,014| |||||| Page 18 ## **Race Against Blood Cancer Detailed Statement of Financial Activities** |**Race Against Blood Cancer**
**Detailed Statement of Financial Activities**||||| |---|---|---|---|---| |Accountancy and bookkeeping
Consultancy fees
**Total of expenditure of other costs**
**Total expenditure**
Net gains on investments
**Net income/(expenditure)**
**Net income/(expenditure) before**
**other gains/(losses)**
Other Gains
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|1,670
-|-
-|1,670
-|934
4,350| ||1,670|-|1,670|5,284| |||||| ||50,424|8,473|58,897|59,063| ||52,032
-|8,473
-|60,505
-|59,757
-| ||30,905|1,323|32,228|(16,515)| ||30,905
-|1,323|32,228
-|(16,515)
-| |||-||| ||30,905|1,323|32,228|(16,515)| ||(1,770)|6,997|5,227|21,742| ||29,135|8,320|37,455|5,227| Page 19